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ABSTRACT

Objective: This study assessed the effect of increased dietary protein intake on adaptation of
energy expenditure and skeletal muscle function at rest and during low-intensity physical activity
in elderly adults.
Methods: Using a randomized, crossover design, 12 adults (7 F, 5 M), aged 82

7 y (mean

SD) completed two 6-day periods of consuming fruit-smoothie beverages twice daily (with
breakfast and lunch) containing 230 kcal and 25 g whey protein (WPro) or 25 g corn-derived
glucose polymer (CHO) (total 460 kcal/day and 50 g/day WPro or CHO).
Results: On day 7 of each period, fasting blood urea nitrogen was 28

9% higher in WPro vs.

CHO (P=0.003), consistent with higher total protein intake. Fasting state energy expenditure and
respiratory ratio at rest and while exercising on a stationary cycle at 1, 10, 20 watts were not
different between WPro and CHO. Gross mechanical efficiency of skeletal muscle progressively
increased from 1 to 10 to 20 watts, but this response was not different between WPro and CHO.
Conclusion: Short-term supplementation with either whey protein or glucose polymer does not
differentially influence fasting state whole body substrate utilization or skeletal muscle work
efficiency in elderly adults.
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LITERATURE AND RATIONALE

From previous research we know protein is critical for maintaining muscle size and
function [3, 18]. This is particularly relevant for old adults who experience a progressive decline
in muscle mass, referred to as sarcopenia. Old adults also experience a decline in substrate
utilization [1, 3, 5, 18, 20]. One way of measuring substrate utilization is through oxygen
consumption at rest and during low levels of exercise [7, 11, 14]. At low levels of exercise,
measuring the volume of oxygen consumed (VO2) presupposes a change in pulmonary VO2
predicts changes in muscular VO2 [4, 7, 13, 14].
Other predictors of muscle function besides substrate utilization as measured by VO2,
include balance and gait. Physiological declines of aging, including sarcopenia, are factors in
decreased balance, gait speed, and stride length [17]. All of these factors are well-researched due
to their correlation with fall risk in the elderly [17, 21].
A previous study from our lab indicated that a short-term inadequate protein diet (0.5
g kg-1 d-1) caused a down-regulation of 35 of 38 gene transcript profiles involved with energy
metabolism in skeletal muscle in old adults [18], compared to when they consumed an isoenergetic diet with 1.2 g of protein kg-1 d-1, representing a 0.7 g kg-1 d-1 difference between
groups protein intakes. Decreased transcripts from inadequate protein intakes imply an adaptive
response in muscle by an increase in the efficiency of substrate utilization to preserve muscle
function. This adaptive response would precede physiological changes of accommodation such
as muscle wasting [18].
Consumption of an energy restricting diet lead to increased skeletal muscle efficiency in
a 2003 study of weight perturbation and the effects of muscle function [14]. The energy
restricting diet decreased subject’s energy and protein intakes by 10%. One could attribute the
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decrease in protein intake as a component of the cause for an increase in skeletal muscle
efficiency. This increase is muscle efficiency accounts for decreased non-resting energy
expenditure associated with energy restriction, demonstrating an adaptive change in skeletal
muscle. Muscle efficiency in this study was quantified by Gross Mechanical Efficiency which is
defined as the ratio of power generated to the change in energy expenditure above resting [14].
Low levels of physical activity were used to calculate GME in this study to account for the
sedentary lifestyles of their subjects.
The primary aim of our study was to investigate the effects of short-term increases in
dietary protein on adaptive changes in skeletal muscle, such as the efficiency of substrate
utilization in old adults. From previous research mentioned above we know decreasing protein
by 0.7 g kg-1 d-1 will lead to changes in muscle transcripts. We hypothesize we will also see an
adaptive change in the efficiency of substrate utilization. Also from past studies mentioned
above, we know weight loss will lead to increased efficiency of substrate utilization in skeletal
muscle. Old adults are in a comparable state to weight loss populations because both involve the
loss of muscle mass [16]. We also hypothesize that increased protein intake in old adults will
lead to decreased muscle efficiency of substrate utilization.
Our secondary aim was to evaluate other indicators of muscle function such as gait speed
and balance. We hypothesize that there will be no effect of protein supplementation on gait and
balance, since we will use a short term dietary intervention.
In this study, we measured substrate utilization efficiency in skeletal muscle in twelve
elderly volunteers (7F, 5M) following 6 days of protein and carbohydrate supplementation. Low
levels of exercise were selected to represent the sedentary lifestyle of older individuals. Their
gait and balance were also measured as muscle function predictors.
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METHODS
Volunteers
Potential volunteers were recruited from University Place Retirement Community in
West Lafayette, Indiana. All participants obtained physician approval prior to starting the study.
The exclusion criteria for the study are listed below:
-

Diagnosis of diabetes mellitus.

-

Status post myocardial infarction (MI) or coronary artery bypass graft (CABG) or
percutaneous transluminal coronary angioplasty (PTCA) within 6 months and/or a
documented ejection fraction of less than 50% .

-

Acute upper respiratory infection.

-

Acute symptoms suggestive of cardiovascular disease.

-

Acute symptoms suggestive of acute congestive heart failure.

-

Uncontrolled hypertension at rest (systolic blood pressure greater than or equal to
160 mm Hg and or diastolic blood pressure greater than or equal to 100 mm Hg).

-

Lower extremity conditions (such as osteoarthritis or peripheral vascular disease),
which preclude the subject from peddling a stationary cycle at 20 watts.

-

Cognitive conditions or limitations that preclude the subject from being able to
understand, comprehend, or interpret instructions, fatigue or symptoms.

-

Routine use of supplemental oxygen during rest or exercise.

Volunteer characteristics are included in Table 2. Twelve volunteers completed the study,
seven female and five male.
All study procedures were approved by the Purdue University Biomedical Institutional
Review Board, and all the volunteers were informed of the purpose, procedures, and potential
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risks of the study prior to signing the informed consent document. There was no monetary
compensation for participation.

Experimental Design
We utilized a randomized, cross-over design for this study (Figure 1). Each volunteer was
tested following two six-day interventions. Between each intervention there was a 7-day washout
period where volunteers returned to their normal diet with no supplementation. During the last
three days of each intervention volunteers recorded all dietary intake on dietary record forms
which were reviewed by a research assistant on test day to ensure completion.
There were two test days on study day 7 and day 21. On each test day, volunteers arrived
in the morning having been fasted overnight for at least 8 hours. Testing lasted approximately 3
hours and included resting and non-resting energy expenditure, gait, balance, a blood draw, and
body composition measurements. Before exercise protocol, volunteers completed a readiness to
exercise questionnaire (Par-Q Survey) to ensure there were no medical changes recently that
would prevent them from performing the exercise safely.
All test day procedures were explained and practiced by the volunteers prior to beginning
the study to allow for equipment acclimation.
The clinical phase of this study was completed from May 2012 to August 2012.

Day
1

2

3

4

5 6
Dietary
Records

Smoothie Mix 1

7
Test
Day 1

8

9

10

11

12

Washout

13

14

15

16

17

18

19 20
Dietary
Records

21
Test
Day 2

Smoothie Mix 2

FIGURE 1. Clinical phase timeline. Test days are on study day 7 and day 21 following a
randomized cross-over design of treatments that lasted 6 days each. The washout period had
no treatment.
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Treatments
Volunteers were provided shake supplements to consume twice daily, once at breakfast
and once at lunch during each of the interventions. Each supplement contained 230 kcal of
energy from mixtures of carbohydrates, fat, and protein (total energy per day was 460 kcal). The
two interventions had different supplements, given in a random crossover design, that differed in
the amounts of macronutrients, but not total energy (Table 1). One supplement was the placebo,
which contained 22 grams of polydextrose, a corn derived glucose polymer (CHO). The other
supplement was the high-protein supplement, which contained 22 grams of whey protein
(WPro). Both supplements contained the same amount of fat.

Table 1. Total Macronutrient Composition Smoothies During WPro and CHO
interventions

Energy, kcal
Fat, g
Carbohydrates, g
Protein, g

WPro Smoothie

CHO Smoothie Mix

225
0.3
56.7
2.5

237
0.5
33.4
25.8

Each smoothie was consumed twice daily during each intervention. Values reported above include 22
grams of added whey protein or polydextrose.

Volunteers were given the supplements frozen and pre-prepared prior to the start of each
intervention. Volunteers were instructed to keep the smoothies frozen until the consumption of
each one. All volunteers were also instructed to consume the smoothies with breakfast and lunch
meals, and were told to compensate within their normal diet to account for the smoothies to
achieve satiation at each meal time.
During each treatment volunteers completed dietary records during the last three days
prior to testing day. This allowed for dietary acclimation for the addition of the supplement. The
results of the dietary records were analyzed using the Nutritional Data System for Research
(NDSR) which is a computer based dietary analysis program. We analyzed total energy intake
10

(kcal), total protein intake (g), and total carbohydrate intake (g) during WPro and CHO
interventions, as well as pre-study for each volunteer.

Resting Energy Expenditure
Volunteers were rested and acclimated to room temperature for at least thirty minutes
prior to testing. A neoprene hood was placed over the subject's head and resting energy
expenditure was measured using indirect calorimetry for thirty minutes. We utilized a TrueOne
2400 Metabolic Measurement System by Parvo Medics (Sandy, Utah, U.S.A.) to measure O2 and
CO2. The last twenty minutes of data were used for analysis to provide acclimation time for the
volunteer during the first ten minutes.

Blood
A fasting blood sample was obtained from an antecubital vein after the volunteer had
rested in a seated position for 15 minutes to obtain a clinical chemistry panel, pre-albumin and
complete blood count with differential.

Non-Resting Energy Expenditure
Fasting non-resting energy expenditure was recorded during a low level cycle egrometer
protocol using indirect calorimetry during each test day. We utilized a TrueOne

2400

Metabolic Measurement System by Parvo Medics (Sandy, Utah, U.S.A.) to measure O2 and CO2,
which was also used in resting energy expenditure.
During this test, the volunteer wore a plastic headpiece, which had a rubber mouthpiece
with a 2-way valve attached to it. A plastic breathing tube was connected from the mouthpiece to
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the pneumotach. The analyzer module measured gas composition from the pneumotach and
processed it to the computer.
Exercise protocol was low resistance to represent the sedentary lifestyle of most old
adults. Volume of oxygen consumed and CO2 produced were recorded and energy expenditure
was estimated using the Weir Equation [7].
To begin the test, the volunteer began by cycling for 2 minutes at 0 watts (no resistance
on the peddles) for a warm up. Volunteers continued peddling at 1 watt for an additional four
minutes after the warm up. The next stage was 10 watts of power for four minutes, followed by
the last stage of 20 watts of power for an additional four minutes of peddling. Finally, there was
a two-minute cool down period at 0 watts again. The entire test lasted 16 minutes, and data were
collected for analysis during the last three minutes of each stage of power (1, 10 and 20 watts).
During pre-study, while the volunteers were acclimated to the cycle they were instructed to find
a comfortable pace, or rotations per minute (rpm), for peddling. The rpm they selected was
recorded and on both test days volunteers were monitored by a research assistant to ensure they
peddled at this same pace.

Gait
Volunteers were instructed to walk at a normal pace over a pressure-sensing walkway,
the GAITRite® system by CIR Systems Inc (Clifton, NJ) . The GAITRite® measured temporal
and spatial gait parameters such as step length, step width, and gait speed at a frequency of 80 Hz
and transferred data to a computer with GAITRite® Gold, Version 3.4 software. The volunteer
had at least twenty-five footsteps recorded by the GAITRite® during test days. Means for stride
length, time in double support, cadence, and gait speed were calculated for each volunteer.
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Balance
Standing balance was assessed using the Biodex Balance System SDTM by Biodex
Medical Systems, Inc. (Shirley, NY). Three 20 second trials were performed with the volunteer
standing on a steady platform force plate on each test day. The average of the three trials was
reported by the machine in three parameters: overall stability index, anterior-posterior balance,
and medial-lateral balance. These indices were then recorded onto a computer for each volunteer.

Body Composition
Body composition measurements were made in the fasting state on testing days using a
bioelectric impedance machine which recorded weight (kg), and percent body fat (%). Fat-free
mass (FFM) was calculated from weight and percent body fat for each volunteer as well.

Calculations
Gross mechanical efficiency (GME) calculations were performed using non-resting
energy expenditure (NREE) and resting energy expenditure (REE) data [14]. REE was
subtracted from NREE (on the cycle egrometer). NREE and REE were corrected for by the ratio
of oxygen consumption and carbon dioxide expiration, or the respiratory exchange ratio (RER),
of each volunteer during rest and each workload. This determined the amount of energy being
expended per minute of cycling. The power generated during cycling at 1, 10, and 20 Watts was
converted to kilocalories (kcal) per minute by the equation 1 W = 0.01433 kcal/min. GME was
then calculated as the ratio of power generated in kcal/minute to the change in energy
expenditure above resting [14].
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Statistical Analysis
Statistical analysis were preformed using SPSS. Values are reported as means
deviations in tables and means

standard

standard error of the mean in figures. All measured outcomes

were analyzed by a repeated measures analysis between treatments. Statistical significance was
defined as a P-value

0.05.
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RESULTS

Volunteer characteristics are presented in Table 2 below. During the study percent body
fat and weight did not change across treatments from pre-study measurements.

Table 2. Pre-Study Volunteer Characteristics
Age, years

82 ± 7

Weight, kg

72.14 ± 11.23

Percent Body Fat, %

33.28 ± 8.76

Fat-Free Mass, kg

48.16 ± 9.73

Resting Energy Expenditure, kcal/min, kcal/day

0.850 ± 0.149 (1223 ± 214)

Values are reported as mean ± standard deviation. N=12 volunteers (7 female, 5 male).

Effect of Carbohydrate and Protein Intervention on Diet and Blood
Volunteers consumed the same amount of total energy during WPro and CHO
interventions (Table 3). However, volunteers consumed significantly less energy during prestudy measurements.

Table 3. Energy Intake Changes Associated With WPro and CHO Interventions
Pre-Study
-1

WPro

CHO

1658 ± 367

a

1945 ± 394

b

1945 ± 393

b

0.95 ± 0.24

a

1.63 ± 0.25

b

0.90 ± 0.35

a

a
a
Carbohydrate (g kg d )
3.12 ± 0.61
3.42 ± 0.72
Superscripts that vary in letters are significantly different (p 0.05).

3.83 ± 1.40

b

Energy intake (kcal
Protein (g

d )

kg-1 d-1 )
-1

-1
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Total protein intake was higher during the WPro intervention versus the CHO
intervention and pre-study measurements. The difference in average protein intake between
WPro and CHO was 0.73 g kg-1 d-1.
Total carbohydrate intake was higher during the CHO intervention compared to the WPro
intervention and pre-study measurements. During the CHO intervention volunteers were
consuming on average 0.41 g kg-1 d-1 more carbohydrates then during the WPro intervention.
The reported change in total protein intake during each of the treatments is supported by
the change in blood urea nitrogen (Figure 2). The WPro group had a 28% higher blood urea
nitrogen (mg/dL) than the CHO group.

Blood Urea Nitrogen, mg/dL

30

25.88

1.62 b

25
20.12

1.12 a

18.63

1.24 a

20
15
10
5
0
Pre-Study

Wpro

Cho

FIGURE 2. Blood urea nitrogen during the WPro and CHO interventions. Values are reported as

mean ± standard error of the mean. Superscripts that vary in letters are significantly different (pvalue 0.05).

Pre-albumin concentration was not different between treatments (p

0.05). Pre-albumin

was 25.5 ± 3.0 mg/dL for the WPro group and 24.9 ± 3.7 mg/dL for the CHO treatment.
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Effect of Protein Intervention on Substrate Utilization
The figure below represents the percent of fat, carbohydrate, and estimated protein
utilized during resting and cycling protocol (Figure 3). At rest volunteers were utilizing 64.2%
and 58.0% fat and 21.8% and 28.0% carbohydrate during WPro and CHO treatments
respectively. Fat and carbohydrate utilization was not significantly different between treatments.

100%

Rest

1 Watt

10 Watts

20 Watts

90%
80%

Percent

70%

42.4
64.2

40.9

40.9

39.4

35.8

34.8

58.0

60%
50%

% Fat

40%
30%
21.8

43.6

45.1

45.1

46.6

50.2

14.0

14.0

14.0

14.0

14.0

51.2

% Carb
% Protein

28.0

20%
10%

14.0

14.0

14.0

0%
WPro CHO

WPro CHO

WPro CHO

WPro CHO

FIGURE 3. Macronutrient utilization during the WPro and CHO interventions at rest and at low

levels of exercise. Percentages were determined from respiratory quotient (RQ) from indirect
calorimetry.

During exercise, fat utilization decreased from 1, to 10, to 20 watts, and carbohydrate
utilization increased, these responses were not different between WPro and CHO.
It should be noted that our methods did not allow for accurate calculations of protein
utilization. Therefore, protein utilization was set at 14% for both interventions at rest and during
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exercise. Previous research in our lab has determined this to be a reasonable assumption for
protein utilization.

Effect of Protein Intervention on Muscle Efficiency
GME increased from 1, to 10, to 20 watts indicating an exercise response. This response
was not different between WPro and CHO interventions.
0.2
Gross Mechanical Efficiency

0.18
0.16
0.14
0.12
0.1

Wpro

0.08

CHO

0.06
0.04
0.02
0
1 Watt

10 Watt

20 Watt

FIGURE 4. Gross Mechanical Efficiency (GME) during the WPro and CHO interventions. Values

are reported as mean ± standard error of the mean. There were no significant changes between
treatments (p-value 0.05).

Effect of Protein Intervention on Gait and Balance
Overall stability index showed no significant differences between treatments (Table 4).
anterior-posterior balance and medial-lateral balance were not significantly changed between
treatments as well.
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Table 4. Balance Index between WPro and CHO Treatments

Overall stability index

Anterior-posterior
balance

Medial-lateral balance

WPro

0.725 ± 0.230

0.408 ± 0.131

0.458 ± 0.207

CHO

0.692 ± 0.264

0.392 ± 0.173

0.467 ± 0.206

All values are expressed as mean ± standard deviation. There were no significant differences between
treatments in OBI, APB, or MLB (p-value 0.05).

Supplementation with WPro or CHO did not influence gait characteristics including time
in double support and stride length in either foot. Gait speed and cadence did not show
significant differences between treatments either (Table 5).

Table 5. Gait Characteristics between WPro and CHO Treatments

WPro
Double Support
(sec)
Stride Length
(cm)

CHO

Right Foot

Left Foot

Right Foot

Left Foot

0. 36 ± 0.08

0.36 ± 0.08

0.33 ± 0.08

0.33 ± 0.08

108.83 ± 20.61

108.37 ± 20.68

112.36 ± 21.91

111.83 ± 22.34

Cadence
(steps/min)

110.65 ± 10.76

113.66 ± 12.07

Gait Speed (cm/s)

100.19 ± 23.39

106.36 ± 25.65

All values are expressed as mean ± standard deviation. There were no significant differences between
treatments in any gait characteristics measured (p-value 0.05).
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DISCUSSION

The first aim of this study was to investigate the effects of supplementation of protein or
carbohydrate on efficiency of substrate utilization in skeletal muscle. We know that inadequate
intakes of protein, or energy restriction accompanied by protein restriction, will increase
efficiency [14, 18]. Using this information, we had hypothesized that efficiency would decrease
with an increase of dietary protein. This study found no evidence of protein supplementation
affecting the efficiency of substrate utilization as measured by gross mechanical efficiency
compared to carbohydrate supplementation.
Previous research has identified adaptive changes in muscle transcript levels involved
with substrate utilization from similar short-term changes in protein ( = 0.7 g kg-1 d-1 ). We had
expected to see changes from an opposite effect of high protein as well [18]. The lack of the
adaptive response indicates short term protein supplementation may not elicit adaptive changes
in muscle, and therefore may have no effect on long term physiological outcomes of
accommodation. In contrast, in short-term inadequate protein intake diets, adaptation markers are
evident and precede accommodation responses of muscle wasting [18].
Our secondary aim was that protein supplementation would not affect gait or balance
characteristics of our volunteers. Gait data such as stride length, time in double support, cadence,
and gait speed were not altered between interventions, nor were balance indices. These responses
were predicted because gait and balance are long term indicators of muscle function and would
most likely not be influenced by short term supplementation.
This study was unique because it investigated short-term high protein intakes for elderly
adults (1.6 g kg-1 d-1 ) and subsequent muscle outcomes. Previous research focused on energy or
protein restricting diets in elderly or sedentary individuals who are experiencing muscle wasting,
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and its effect on muscle function. Since dietary protein is so critical in maintaining muscle size
and function, research focused on supplementation is also necessary for old populations.
This study was also novel because it investigated muscle efficiency at very low powered
stationary cycle ergometry. Rosebaum et at in 2003, found that changes in muscle work
efficiency are most prevalent at low levels of physical activity [14]. Also, this study reported
that using a cycle ergometer can be a surrogate for activities of daily living [14]. Their subjects
were not comparable in age to ours, but they were confined to a research facility and considered
sedentary. A sub-maximal test, as used in previous research on muscle function in old people
may not be appropriate. Utilizing low powered exercise such as in the present study may be more
representative of the activities of daily living of old people.
This study was limited in statistical power due to the small number of subjects that
participated. This study was also limited because it was not a complete dietary intervention,
rather just a supplementation. Our results show increases in total energy intake during
supplementation from pre-study measurements due to lack of complete compensation. We know
from previous research that increases in energy intake will influence resting and non-resting
energy expenditure, so it is important to keep volunteers on an iso-caloric diet while
manipulating their protein and carbohydrate intake [14].
Future research should be aimed at investigating the effects of protein supplementation
for longer interventions in elderly adults. It would be especially important for a longer
intervention to have maintained weight of volunteers by having them consume an iso-caloric diet
as mentioned above. Also future research should focus on comparing inadequate versus
supplemental protein intakes. The present study included a group with supplemental protein
during WPro (1.63 g kg-1 d-1), but the CHO control group also consumed adequate protein too
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(0.9 g kg-1 d-1 ). Since we know inadequate protein leads to adaptive changes in muscle, having
a low protein group could serve as a control for the protein supplemented group.
In conclusion, the present study represented two groups of elderly individuals who
consumed short-term diets of adequate protein intakes, and high protein intakes. No adaptive
changes in muscle occurred between high protein (WPro) or adequate protein (CHO) intakes as
measured by substrate utilization at rest and during exercise. The exercise protocol was low
intensity, which represented activities of daily living for old people. This could be indicative that
supplementation of protein to already adequate protein intakes may not elicit any later changes of
accommodation in elderly individuals.
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Men and Woman Age 65 and Older
Needed For Research Study
Dr. Wayne Campbell in the Department of Nutrition Science,
Stone Hall, Purdue University, West Lafayette, IN is
conducting a research study to assess diet and muscle
function in adults 65 years and older. This study will be
conducted at University Place Senior Living Community.
This study includes 2 parts, over a period of 26 days.
Part 1 of this study will last approximately 5 Days with 1 Test Day
Part 1 and 2 of this study will last approximately 26 Days with 3 Test Days

Measurements Will Include:
Resting Energy Expenditure
Exercise Energy Expenditure (Stationary Bike Exercise)
Body Composition(lean and non-lean body tissue)
Blood Chemistry Profile
Diet Analysis
Physical Energy Level Questionnaires
You Will Be Asked To Consume A Dietary Supplement In
Part 2
Are you 65 or older and in general good health, non-smoking, do
not have diabetes, or acute heart or lung diseases? Are you
physically able to ride on a stationary bike at an easy pace for up
to 16 minutes? If so, please contact:

Kristen Clark at clarkk@purdue.edu Or
Kathryn Sands at 765-496-6480
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RESEARCH PARTICIPANT SCREENING
CONSENT FORM

Diet and Muscle Function in Older Adults
Professor Wayne W. Campbell, Ph.D.
Purdue University
Department of Nutrition Science
Purpose of Research
The purpose of this study is to assess if your diet, body composition, and physical
abilities affect how many calories your body burns at rest and while doing low-intensity
exercise.
Specific Procedures
The information you will provide during screening may also be used for the study. You
have been asked to fill out a Medical History Questionnaire and give your doctor a form
to send back to us that determines your eligibility. You will then return that information
back to the Department of Nutrition Science at Purdue University. We will then schedule
a meeting to review your information and describe the study in detail. Once you have a
good understanding of what we are asking you to do and if you agree, then we can start
the study.
Screening measurements: # OF DAYS: 1 TOTAL ESTIMATED TIME: ~ 1 hour
Medical History Questionnaire, Physician’s Clearance Form:
You have provided (to the best of your knowledge) a complete history of all of your
medical disorders during the screening process. To the best of your knowledge, you are
free from disease that might make participation in this study unsafe. You will let
Professor Campbell know all of the medications, drugs, and/or supplements that you
currently take. You have also provided your physician’s clearance form allowing you to
participate in this study. If requested by Professor Campbell, you will agree to stop taking
some or all of these medications, drugs, and/or supplements two weeks before and
during this study. You will not be asked or required to change any of your
prescription drug intake without the authorization of your personal physician. It is
expected that you will not take any new medications, drugs, and/or supplements during
this study. It is expected that you will not change the dose of medications that you keep
taking during the study. If you find that you must change the dose of your medications,
you will contact Professor Campbell before the medication change or as soon as possible
immediately afterward.
Duration of Participation
Screening procedures will take approximately 1 hour to complete.
Benefits to the Individual
There is no direct benefit for participating in this study. However, you may benefit from
the information given to you concerning your general overall health.
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Risks to the Individual
There are no known risks when completing questionnaires. There is a risk of breach of
subject confidentiality but safeguards are in place to minimize this risk as outlined
above.
Compensation
You will not be paid for completing this screening process.
Injury or Illness
Purdue University will not provide medical treatment or financial compensation if you
are injured or become ill as a result of participating in this research project. This does
not waive any of your legal rights nor release any claim you might have based on
negligence.
Confidentiality
The project's research records may be reviewed by the Purdue University Institutional
Review Board, Office of Human Research Protections, and by departments at Purdue
University responsible for regulatory and research oversight. All records will be kept
confidential in locked cabinets/rooms for at least three years and after the close of the
study. The data will be kept indefinitely and may be used for future studies. All records,
data, and specimen will only be available to the principle investigator or his designee for
analysis purposes.
Voluntary Nature of Participation
You do not have to participate in this screening evaluation. If you agree to participate
you can withdraw your participation at any time without penalty.
Contact Information
If you have any questions about this research project, you can contact Professor Wayne
W. Campbell at (765) 494-8236. If you have concerns about the treatment of research
participants, you can contact the Institutional Review Board at Purdue University, Ernest
C. Young Hall, Room 1032, 155 S. Grant St., West Lafayette, IN 47907-2114. The
phone number for the Board is (765) 494-5942. The email address is irb@purdue.edu
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Documentation of Informed Consent
I HAVE HAD THE OPPORTUNITY TO READ THIS PARTICIPANT SCREENING
CONSENT FORM AND HAVE THE RESEARCH STUDY EXPLAINED. I HAVE HAD
THE OPPORTUNITY TO ASK QUESTIONS ABOUT THE RESEARCH PROJECT AND
MY QUESTIONS HAVE BEEN ANSWERED. I AM PREPARED TO PARTICIPATE IN
THE SCREENING EVALUATION FOR THE RESEARCH PROJECT DESCRIBED
ABOVE. I WILL RECEIVE A COPY OF THIS CONSENT FORM AFTER I SIGN IT.
_________________________________
Screening-Participant’s Signature

_______________
Date

_________________________________
Researcher’s Signature

_______________
Date

Please check only one of the two boxes below

You agree to allow the use of your data and/or specimens collected during this
screening evaluation to be used for future research that is unrelated to this study.
_________________________________
Screening-Participant’s Signature

_______________
Date

You request your data and/or specimens collected during this screening evaluation
to NOT be used for any future research that is unrelated to this study.
_________________________________
Screening-Participant’s Signature

_______________
Date
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RESEARCH PARTICIPANT STUDY CONSENT FORM

Diet and Muscle Function in Older Adults
Wayne W. Campbell, Ph.D.
Purdue University
Department of Nutrition Science
Purpose of Research
This is a two-part project to improve our scientific understanding of diet, body composition
and energy use in older adults. Part 1 will assess if your diet, body composition, and physical
abilities affect how many calories your body burns at rest and while doing low-intensity
exercise. Part 2 will assess how dietary protein intake affects muscle energy use and your
daily perceived vigor.
Medical History Questionnaire, Physician’s Clearance Form
You have provided (to the best of your knowledge) a complete history of all of your medical
disorders during the screening process. To the best of your knowledge, you are free from
disease that might make participation in this study unsafe. You will let Professor Campbell
know all of the medications, drugs, and/or supplements that you currently take. You have
also provided your physician’s clearance form allowing you to participate in this study. If
requested by Professor Campbell, you will agree to stop taking some or all of these
medications, drugs, and/or supplements two weeks before and during this study. You will not
be asked or required to change any of your prescription drug intake without the authorization
of your personal physician. It is expected that you will not take any new medications, drugs,
and/or supplements during this study. It is expected that you will not change the dose of
medications that you keep taking during the study. If you find that you must change the dose
of your medications or a new medication, you will contact Professor Campbell before the
medication change or as soon as possible immediately afterward.
Procedures To Be Used
This study includes two parts. Part 1 is shown on the study table (next page) as study days
one through five (1-5). Part 2 will consist of days 6-26 on the study table below.
After participating in Part 1, if you are interested in continuing with our research study, you
can participate in Part 2.
Part 1

Description

Day
0

Screening
Study and Equipment
Review
Diet Supplement
Wash out Period
Body Composition
Blood Sample
Energy Expenditure

X

Day
1

Part 2

Days Day
2-4
5

Days Days Day
6-8
9-11 12

Days Days Days Day
13-19 20-22 23-25 26

X
X

X

X

X

X
X
X
X

X
X
X

X
X
X
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Bicycle Test
Physical Ability Test
Dietary Records
Energy Level Survey

X
X
X
X

X
X
X
X

X
X
X
X

Part 1: The study will consist of one test day. Prior to the test day, you will be asked to record
everything you eat, how it was prepared, and the quantity consumed throughout the days on
a 3-Day food record sheet, which will be provided. Also during these three days, you will be
asked to complete an energy-level survey with each meal. This survey will have you rate
your daily perceived energy level.
Part 2: You will continue to consume your normal diet with the addition of a daily nutritional
supplement. At the beginning of the supplementation, you will be asked by our research
team to consume 2 supplements/day. One will be consumed at the first eating occasion of
the day (i.e., breakfast) and the second one will be consumed at the second eating occasion
of the day (i.e., lunch). You will be asked to consume these supplements for two 6-day
interventions (total of 12 days). Between these interventions, there will be a washout period
of no supplements to be consumed lasting from Day 13-19. The supplements will be
composed of dietary carbohydrates, protein and fat (total of 500calories/day). The
supplements for each intervention will differ in the amount of protein, consisting of either a
high protein or low protein shake.
During these interventions, on the last three days you will be asked to record everything you
eat, how it was prepared, and the quantity consumed throughout the days on a 3-Day food
record sheet provided. Also during these last three days both interventions you will be asked
to complete an energy-level survey with each meal. This survey will have you rate your daily
perceived energy level.
Test Days
Test days include days 5, 12, and 26. All three of these test days will be identical. Each test
day will last approximately 3.5 hours. You will need to be in a fasted state. You will be asked
questions about any recent changes in your health. You will also be asked to complete the
following tests conducted by a member of our research staff:
A. Body Composition:
Your height and weight will be measured. The amount of lean to non-lean tissue will
be determined by stepping on a scale for about 10-15 seconds while barefoot. You
may hold on to handle bars for balance.
B. Blood sample:
You will have about 4 teaspoons of blood drawn from a vein in the crook of your arm
using a needle. The sample will be used to measure clinical indicators of your health,
including liver and kidney functions, risk of diabetes, acute illness, and if your body
has adequate protein.
C. Energy Expenditure:
You will lie on a bed in a reclining position for a total of 60 minutes. During the first
30 minutes, no measurements will be taken and you will simply lie quietly and relax.
After 30 minutes, a large clear plastic hood will be placed over your head and the
amount of oxygen you breathe in and out will be measured for the next 30 minutes.
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You will be able to breathe normal room air, which is continually flowing into the
hood during the procedure. This test is used to measure how many calories of
energy you are burning while resting.
D. Bicycle Test:
This test measures how many calories you are using during easy-paced exercise on
the stationary bike. You will pedal for approximately 16 minutes including a warm up
and cool down session. During the test, a plastic headset will be worn to hold the
mouthpiece and tubes for the air measurements. You will breathe through a
mouthpiece attached to plastic tubes. Room air will always flow through the tubes. We
will measure how fast and how much air you are taking in and breathing out.
Periodically, you will be asked to rate how hard you are exercising. A heart rate
monitor will be used to measure your heart rate before, during, and after exercise.
After the bicycle test, you will receive a snack and beverage before continuing with
any further testing.
E. Physical Ability Tests:
A series of tests will be done to determine your physical abilities.
Postural Stability
You will simply be required to fit a square object through an opening of varying size
while reaching movements and posture are monitored while standing on the force
plate.
Walking Gait
You will walk across a pressure-sensing walkway. The GaitRight measures gait
parameters such as step length, step width, and gait speed.
There is a hierarchy of gait tasks. In the first level, you will be seated. In the second
level, you will walk over a walkway with no obstacles. In the third level, obstacles will
be placed on the walkway where you must step over and continue walking. In the
fourth level, you will walk and step over obstacles while carrying a tray with four
plastic cups.
F. Dietary Food Record:
A member of Prof. Campbell’s research staff will review your 3-Day food records with
you to make sure the information is complete and accurate.
Duration of Participation
The study will take a minimum of 5 days to complete, but may take longer depending on your
availability for testing for Part 1. If you participate in Part 1 and Part 2, the study will take a
minimum of 26 days to complete, but may take longer depending on your availability for
testing.
Benefits to the Individual
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There is no direct benefit of participating in this study. However, you may perceive a benefit
from knowing your body composition, how many calories you burn, and the results of the
blood analyses.

Risks to the Individual
The following risks exist:
Blood Draw
You may experience discomfort and the development of a small bruise and/or
infection at the puncture site on your arm where the blood is drawn. You may also
feel lightheaded and there is a slight risk of fainting. The amount of blood drawn is
about four (4) teaspoons (two-thirds of a fluid ounce or 20 milliliters) and is small
enough that it should present no hazard to your physical well-being.
Energy expenditure
There is a risk of a feeling of claustrophobia occurring when clear plastic hood is
placed over your head. If this occurs, you can always remove the hood or signal
to the attendant and he or she will remove it for you.
Bicycle Testing
The cycling exercise should feel easy to moderately hard. During exercise, we
will monitor your heart rate and stop the test at any time if your heart rate goes
above an acceptable level for submaximal exercise based on age. If you feel
discomfort, you can stop peddling at any time during the test. The bicycle seat
could potentially be uncomfortable as well. Risks include shortness of breath,
uncomfortable fit of mouthpiece, muscle and joint soreness, cardiac arrest, or
death. Qualified responders will be on hand to provide assistance if the need
arises.
Functionality Tests:
There is a risk of falling. If you should feel any discomfort, fatigue,
lightheadedness, or chest pains the tests can be stopped.
Supplement (Part 2 only):
You may experience some gastro-intestinal discomfort with the supplement used
in the study.
There is risk of breach of confidentiality. There are no known risks associated with:
weight and height measurements, fat body tissue measurements and completing
questionnaires and surveys.
Compensation
You will not be paid any money for doing this research study.
Injury or Illness
Purdue University will not provide medical treatment or financial compensation if you are
injured or become ill as a result of participating in this research project. This does not
waive any of your legal rights nor release any claim you might have based on negligence.
Confidentiality
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The project's research records may be reviewed by the Purdue University Institutional
Review Board, Office of Human Research Protections, and by departments at Purdue
University responsible for regulatory and research oversight. All records will be kept
confidential in locked cabinets/rooms for at least three years and after the close of the
study. The data will be kept indefinitely and may be used for future studies. All records,
data, and specimen will only be available to the principle investigator or his designee for
analysis purposes.
Voluntary Nature of Participation
You do not have to participate in this study. If you agree to participate you can withdraw
your participation at any time without penalty.
Human Subject Statement:
If you have any questions about this research project, you can contact Professor Wayne W.
Campbell at (765) 494-8236. If you have concerns about the treatment of research
participants, you can contact the Institutional Review Board at Purdue University, Ernest C.
Young Hall, Room 1032, 155 S. Grant St., West Lafayette, IN 47907-2114. The phone
number for the Board is (765) 494-5942. The email address is irb@purdue.edu.
Documentation of Informed Consent
I have had the opportunity to read this consent form and have the research study explained.
I have had the opportunity to ask questions about the research project and my questions
have been answered. I am prepared to participate in the research project described above. I
will receive a copy of this consent form after I sign it.
Participant Consent for Part 1 of our research:
_________________________________
Participant’s Signature

___________________
Date

_________________________________
Printed Name

___________________
Date

_________________________________
Researcher’s Signature

___________________
Date

Participant Consent for Part 2 of our research (to be signed after completion of Part 1):
_________________________________
Participant’s Signature

___________________
Date

_________________________________
Printed Name

___________________
Date

_________________________________
Researcher’s Signature

___________________
Date

Please check only one of the two boxes below:
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I agree to allow the use of my data and/or specimens collected during this research
project to be used for future research that is unrelated to this study.
______________________________
Participant’s Signature

__________________
Date

I request my data and/or specimens collected during this research project to NOT
be used for any future research that is unrelated to this study.
___________________________
Participant’s Signature

__________________
Date
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Physician Clearance Form
To Whom It May Concern:
Patient, ______________________, has expressed interest in participating in a two part research
study being conducted at University Place Senior Community. The study is being conducted
by Professor Wayne Campbell in the Department of Nutrition Science at Purdue University.
Part 1.) The purpose of the this study is to determine the metabolic effects of using low
intensity exercise to represent the recreational lifestyle of adults 65yrs and older.
Part 2.) The purpose of this study is to investgate the effects of a normal or high dietary
protein intake (supplemented through a nutritional shake) on muscle function in adults
65yrs and older. We are also investigating chronic fatigue in this population.
During the study the following parameters will be measured:
Resting Metabolic Rate
Blood Lipids
Intake
Body Composition (fat and lean mass)
functions)
Physical Function test

Blood Glucose

Body Wt

Dietary

Blood Clinical Chemistry Panel (including kidney& liver

Energy Expenditure during low intensity exercise using a Stationary Cycle:
Each participant will sit on a stationary cycle and pedal against very light to moderate
resistance for up 16 minutes.
Heart rate and preceived exertion will be monitored. As well, medical emergency services
are available at University Place Senior Community if needed.
Cycle protocol will include the following:
A 2 minute warm up period at 0 (very light) resistance, 4 minutes of cycling at 0 (very
light) resistance , 4 minutes of cycling at 10(light) watts of resistance, 4 minutes of cycling
at 20 (moderate) watts of resistance, and a 2 minute cool down period at 0 (very light)
watts resistance.
The exclusion criteria are as follows:
Age < 65 years
Diagnosis of diabetes mellitus.
Post myocardial infarction (MI) or coronary artery bypass graft (CABG)
surgery within 16 weeks
Post percutaneous transluminal coronary angioplasty (PTCA) within 4
weeks.
Acute upper respiratory infection, symptoms suggestive of cardiovascular
disease and symptoms suggestive of acute congestive heart failure.
Uncontrolled hypertension at rest (systolic blood pressure greater than or equal
to 160 mm Hg and or diastolic blood pressure greater than or equal to 100 mm
Hg).
Lower extremity conditions (such as osteoarthritis or peripheral vascular
disease), which preclude the subject from peddling a cycle at 20 watts.
Cognitive conditions or limitations that preclude the subject from being able to
understand comprehend or interpret instructions, fatigue or symptoms.
Routine use of supplemental oxygen during rest or exercise.
Lactose Intolerant
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This study has the approval of the Institutional Review Board at Purdue University. As part
of the protocol, physicians’ clearance is required. Please sign and date this form if you agree
that this patient is suitable to participate in this study. If you need more information or
have any question regarding this study please call.
Thank You, Wayne Campbell, Ph.D., Professor, Dept of Nutrition Science, Purdue
University, 765-496-6342

Physician Comments:

I have reviewed the information and in my professional opinion, the described study
activities are not contraindicated for this patient.

_____________________
Physician Name

__________
Date

_____________________________________________
Physician Name (Printed)

You may return this form by fax to our office of Nutrition Science at Purdue
University at 765 494 0674.
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Department of Nutrition Science
Wayne W. Campbell, Ph.D.
MEDICAL HISTORY QUESTIONNAIRE
The following questions are designed to obtain a thorough preliminary medical history.
The information you provide will help us to make the best determination about your
eligibility for a particular study. Please answer all questions and provide as much
information as you possibly can. This questionnaire, as well as any other medical
information you provide will be kept confidential and will not be shared with any
unauthorized person or organization unless you specifically request us to do so.
Name:

________________________________

Street Address: _________________________________
City, State, Zip: _________________________________
Telephone number: Home (
Date of Birth: __________
mm-dd-yy
Sex:

)__________ Work (

)______________

Age: _____

M _____ F _____

Height _____

Weight _____

Personal Physician's Name: __________________________Phone___________
Address: _________________________________________________________
_________________________________________________________
Last grade completed in elementary or high school: ____________
Education completed since leaving elementary or high school:
_____ None
_____ Vocational School
_____ Community or Junior College
_____ Four Year College
_____ Graduate School
_____ Professional School
Occupation
Current occupation or occupation at retirement:
_____________________________________________________________

Marital Status
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_____ Married
_____ Divorced
_____ Widowed

_____ Single, never married
_____ Separated

Living Situation
_____ Alone
_____ With family member(s)
_____ With non-family members(s)
Do you have any pets? No _____ Yes _____ (please describe)
__________________________________________________________
Race
____Caucasian (white)
____ African American
____ Asian/Pacific Islander

____Hispanic
____American Indian
____Other, please indicate

Personal Health History
Have you ever been hospitalized or had surgery?

Yes _____

No _____

Please list all hospitalizations and surgeries to the best of your recollection
Hospitalized for
Age when
Disease/Operation
Duration
Hospitalized
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
List any disease or illness you have had not listed on the previous page (e.g., mumps, measles, broken
bones, etc.)
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
Are you allergic, sensitive or intolerant of any foods or medications? Yes___ No___
If yes, please describe:
Food:___________________________________________________________
Medication:_______________________________________________________
Other:___________________________________________________________

Are you currently seeing a doctor or other health care provider for any reason?
Yes _____ No _____
If yes, please explain: ____________________________________________________
_____________________________________________________________________
Do you have, or have you ever had any of the following conditions?
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Alteration of your ability to remember

Yes _____

No _____

Recurring headaches

Yes _____

No _____

Recent changes in your vision

Yes _____

No _____

Numbness of an arm or leg

Yes _____

No _____

Weakness of an arm or leg

Yes _____

No _____

Difficulty in speaking or slurred speech

Yes _____

No _____

Fainting or dizziness

Yes _____

No _____

Difficulty in walking (staggering)

Yes _____

No _____

Shortness of breath

Yes _____

No _____

Lung or Respiratory Disease

Yes _____

No _____

Rheumatism or arthritis

Yes _____

No _____

Pain in joints

Yes _____

No _____

Osteoporosis

Yes _____

No _____

Osteopenia

Yes _____

No _____

Heart disease

Yes _____

No _____

Epilepsy

Yes _____

No _____

Tumors

Yes _____

No _____

Mental illness

Yes _____

No _____

Bleeding or clotting disorders

Yes _____

No _____

Risk for infectious diseases
Yes _____
(AIDS, IV drug use, blood transfusions, hemophilia, hepatitis)

No _____

Skin: rashes, lumps, moles, itching, eczema

Yes _____

No _____

Nose, sinuses: frequent colds, sinus trouble
nose-bleeds, deviated septum

Yes _____

No _____

Neck lumps, swollen glands, pain or stiffness

Yes _____

No _____

Breasts: lumps, nipple discharge, pain
Yes _____
or discomfort
For women: Date of last mammogram ___________

No _____

High blood cholesterol
Date of last reading ______

No _____

Yes _____
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Stomach: chronic indigestion, ulcer, hiatal hernia,
heartburn, trouble swallowing, vomiting.

Yes _____

No _____

Intestine: constipation, diarrhea, change in bowel
habits, irritable bowel disorder, colitis, polyps.

Yes _____

No _____

Rectum: hemorrhoids, bleeding, polyps

Yes _____

No _____

Liver, gallblader: hepatitis, gallstones

Yes _____

No _____

Urinary: frequent urination, urgency, burning,
pain, blood in urine, infection, kidney stones

Yes _____

No _____

Incontinence: Loss of bladder or rectal control

Yes ______ No _____

Do you use adult undergarment products
such as Depends?

Yes _____

No _____

Have you ever had any form of cancer, skin or other?
Yes _____

No _____

If yes, what kind: ______________________________

Do you have diabetes mellitus (high blood sugar)?
Yes _____

No _____

If yes, when and what kind of treatment did/do you receive:
Insulin _____

Diet _____

Pills _____

No treatment _____

Is there a family history of diabetes mellitus?
Yes _____ No _____
Have you ever had or been told that you had high blood pressure?
Yes _____

No _____

If yes, when and what kind of treatment or medicine did/do you receive:
________________________________________________________________

Do you have any chronic illnesses?
Yes _____

No _____

If yes, please explain:
________________________________________________________________________
Do you have any problems with constipation or diarrhea?
Yes _____ No _____
If so, how do you usually remedy it?
____________________________________________________________________________________
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Have you ever been treated for an eating disorder?
Yes _____ No _____
If yes, when and what type? _________________________________________________

List all the prescribed medications you are currently taking:
Medicine
Cause of Medication
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
List all the over-the-counter Physician recommended medications you are currently taking:
Medicine
Cause of Medication
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________

List all the over-the-counter medications you are currently taking:
Medicine
Cause of Medication
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________

Would you be willing to have your Physician give written approval for you to discontinue only your
Physician recommended and self-prescribed medications for the duration of the study?
If yes, please have your Physician sign and date the bottom of this page indicating his/her approval.

____________________________
Physician Name

______________
Date

____________________________
Volunteer Name

______________
Date

Physician Comments:
____________________________________________________________________________________
____________________________________________________________________________________

For Females Only
Do you currently have menstrual periods?

Yes _____

No _____
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If yes, is your cycle regular?

Yes _____

No _____

What is the typical length of your menstrual cycle? ______ days
What is the typical length between menstrual periods? ______ days
When was your last menstruation? __________________________
Do you or have you ever had menstrual problems, vaginal discharge, irregular bleeding, sexually
transmitted illness.
Yes _____ No _____
If yes, please explain: ____________________________________________________
Are you sexually active?

Yes _____

No _____

If yes, what type of contraceptives do you use? _________________________________

Age of menopause if applicable: ________________
Type of menopause:

_____ natural

Estrogen replacement: Yes _____

_____surgical

______ other

No _____

If yes, please explain:
____________________________________________________________________________________

Last PAP smear:
______________________________
Number of pregnancies:
______________________________
Number of births:
______________________________
Type of delivery:
______________________________
Your age at time of birth (s):
______________________________
Date of Hysterectomy (if applicable): __________________________
Reason:
___________________________________________
Dietary Information
Are you currently taking any vitamins, minerals or health food supplements at least once per week on a
regular basis? Yes _____ No _____ If yes, please describe:
Supplement
Amount How often
How long
Reason______
____________________________________________________________________________________
____________________________________________________________________________________

Would you be willing to stop your vitamins, minerals or health food supplements if needed while
participating in a study? Yes _____ No _____
Are you currently following a special diet (i.e., vegetarian, diabetic, low fat, lactose free)?
Yes _____

No _____

If yes, what kind? ______________________________

Has this diet been prescribed by your health care provider? Yes ____

No ____
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If accepted for a study, are you willing to follow a diet that may vary from your current food intake?
Yes _____ No _____
Have you had a weight loss or gain in the last 6 months? Yes _____
If yes, how much?

_____lbs.

How do you describe your appetite?

Gain _____

No _____

Loss _____ (check one)

Poor _____

Fair _____

Good _____

When required during the study, would you be willing and able to eat only the items provided by the
Nutrition Laboratory, Purdue University?
Yes _____

No _____

Do you have problems eating high-fat foods? Yes _____

No _____

Do you have any food allergies/intolerance? Yes _____

No _____

If so, please explain:
_____________________________________________________________________________
_____________________________________________________________________________

Do you drink caffeinated beverages? (coffee, tea, soda) Yes _____ No _____
If yes, how many caffeinated beverages do you drink in an average day? ______/day
If required during a study, would giving up caffeine cause any problems for you?
Yes _____

No _____

Do you drink alcoholic beverages? Yes _____

No _____

If yes, how many alcoholic beverages do you consume in an average week? ______/wk
Can you forego drinking alcoholic beverages for the duration of a research study?
Yes _____

No _____

Do you have a problem drinking milk or eating dairy products?
Yes _____ No _____
If yes, what happens?
_____________________________________________________________________________

How many meals to you typically eat in a day? ______________
Please list the typical times that you eat throughout the day (meal #1 is the first meal of the day; only list
the times for the meals that you eat):
Meal #1: ___________
Meal #2: __________
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Meal #3: ___________
Meal #4: ___________
Meal #5: ___________
Meal #6: ___________
Meal #7: ___________
Exercise History
What kind of work are you engaged in? ______________________________________
How long have you been engaged in this type of work? _________ years.

In terms of physical demands, how would you rate your position?
very active

active

slightly active

sedentary

In which of the following positions do you spend most of your time at work?
sitting

sitting and standing

walking and standing

About how much time on the job do you spend sitting?
all

more than 1/2

about 1/2

less than 1/2

Do you lift and carry heavy things in your work?
Do you take walks in good weather?

almost none

frequently
frequently

sometimes
sometimes

infrequently
infrequently

Do you do manual work at home (e.g., painting, repairing, etc.)
frequently

sometimes

infrequently

Do you mow your lawn or work in your garden?

frequently

sometimes

infrequently

Do you take part in sports during their season?

frequently

sometimes

infrequently

List the sports and/or exercise that you engage in and the number of times per week:
____________________________________________________________________________________
____________________________________________________________________________________

In the past, were you a regular sport or exercise participant?
frequently

sometimes

infrequently

When and why did you cease participating?
Approximate date: __________________
Reason for quitting: ________________________________________________
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Do you have any condition that would prevent you from being physically active?
Yes _____ No _____
If yes, please explain:_______________________________________________
Smoking History
Do you smoke cigarettes at present?

Yes _____

If yes, how many packs per day?

No _____

less than 1/2 pack
1/2 to 1 pack
1 to 2 packs
more than 2 packs

Do you inhale?

Yes _____

How long have you been smoking?

less than 1 year
1 to 5 years
more than 5 years

Did you smoke cigarettes in the past and quit permanently?Yes _____
If yes, how many packs per day did you smoke?

Did you inhale?

No _____

less than 1/2 pack
1/2 to 1 pack
1 to 2 packs
more than 2 packs
Yes _____ No _____

When did you quit?

Do you smoke cigars at the present?

No _____

less than 1 year
1 to 5 years
more than 5 years
Yes _____

If yes, how many cigars per day?

No _____

less than 2
2 to 5
more than 5

Did you smoke cigars in the past and quit permanently? Yes _____

No _____

Do you smoke a pipe at present?

No _____

Yes _____

If yes, how many pipefulls do you smoke per day?

less than 2
2 to 5
more than 5

Did you smoke a pipe in the past and quit permanently? Yes _____

No _____
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Appendix 6: Pre-Exercise Questionnaire
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Pre-Exercise Questionnaire
Subject Name: _______________________________________
Date: ___________________ Time: _____________________
Has your health status changed since the last time we saw you?
No Changes
YES (please describe)

Have your medications (types or dosages) changed since the last time we saw you?
No Changes
YES (please describe)

Have you experienced any injuries or illness since the last time we saw you?
No
YES (please describe)

Have you experienced any symptoms of illness including, but not limited to, dizziness,
nausea, lightheadedness, fatigue, gastrointestinal distress, diarrhea, shortness of breath,
chest pain or fever within the past 48 hours?
No symptoms
YES (please describe)

Subject Initials: _________________________________
Investigator Name: ______________________________
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Appendix 7: Food Record Forms
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Indiana Clinical and Translational Sciences
Institute

Completing Multiple Day Food Records
General Instructions for Keeping Records
Please use ink and write clearly.
Please complete the food records for the number of days and specific days of the
week (i.e. weekend days vs. weekdays) that were specified by the dietitian or study
coordinator.
Remember to not change your eating habits.
Record everything you eat and drink in a 24 hour period, from midnight to midnight,
preferably right after it’s consumed.
Write each food, beverage, or ingredient on a separate line.
Start each new day on a new page. If you need more than one page per day, please
mark the pages.
Fully describe foods & beverages, including brand names, when possible. If the item is
cooked, please describe how it is prepared (e.g. boiled, broiled, grilled, baked, fried,
etc.)
Estimate the portion sizes of everything you consume. Refer to page 2, “Seven Ways
to Size up your Servings,” for help with estimating portion sizes.
Include items you add at the table. List them on separate lines. (e.g. margarine on a
baked potato)
You may attach copies of recipes.
Breads
Indicate if whole wheat, white, etc.
Record number, size, & portion.
Include sandwich condiments & additions
(e.g. lettuce, tomato, mustard)
Beverages
List the type of milk – whole, 2%, etc.
List whether fruit juice is fresh, frozen,
sweetened, and if calcium fortified.
Cereals
Record cooked cereal in portions of cup and
amount eaten after cooking.
Record dry cereal in level portions of cup.
Note if milk, fruit, sugar, etc are added and
the amounts (e.g. 1 tsp brown sugar).
Cheese
Record the size in inches or weight in oz.
Describe fat content – skim, 1%, 2%, whole.

Desserts
List commercial brand or
homemade.
Record portion size of cakes, pies,
and cookies by indicating thickness,
diameter, width or length (e.g.
brownie 2” x 2”)
Candy - # of pieces or size in
ounces
Fruits
Indicate if fresh, frozen, dried, or
canned.
If whole, record # eaten and size (1
apple, 3” diameter).
Meats, Fish, Poultry
Record size in inches or weight in
ounces, without bone, after cooking.
Indicate leanness (e.g. % fat ground
beef).
Describe how meat was prepared.
Mixed Dishes
Stews, soups, casseroles, meat
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Remember:

1

3 ounces of meat is about the size and thickness of a deck of
playing cards or an audiotape cassette.

2

A medium apple or peach is about the size of a tennis ball.

3

1 ounce of cheese is about the size of 4 stacked dice.

4

1/2 cup of ice cream is about the size of a racquetball or tennis
ball.

5

1 cup of mashed potatoes or broccoli is about the size of your
fist.

6

1 teaspoon of butter or peanut butter is about the size of the tip
of your thumb.

7

1 ounce of nuts or small candies equals one handful.
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Participant ID#:_________________________
Day of Week: ____________________
Date:___/___/___
MEAL
B = Brkfast
L = Lunch
D = Dinner
S = Snacks

PLACE
TIME
METHOD OF
PREPARED CONSUMED PREPARATION
H = Home
e.g. Baked,
R = Restaurant
Broiled, Fried,
O = Other
Raw, Canned etc.

AMOUNT
& / OR SIZE

FOODS & BEVERAGES

(Include brand names, if known)

(e.g. cups, oz,

tsp, Tbsp, inches)
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